Literature DB >> 16282188

CD3-antibody therapy in new-onset type 1 diabetes mellitus.

Michael J Haller, Desmond A Schatz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16282188     DOI： 10.1056/NEJM200511103531920

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Efforts to prevent and halt autoimmune beta cell destruction.

Authors:  Michael J Haller; Mark A Atkinson; Desmond A Schatz
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

2.  Progress, but not yet ready for clinical use: interrupting immune-mediated destruction of pancreatic beta cells in type 1 diabetes.

Authors:  Carla J Greenbaum
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.